coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Winsford PCN, Cheshire West and Chester (LAD) · Health Inequalities Profile

    PCN U02678 · NHS Cheshire and Merseyside Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    38,799

    Registered population

    61.2% aged 18–64

    17.6%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.8%

    Ethnic minority (non-White)

    1.6% Asian · England 9.6%

    30.7%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~10,865

    Core20 residents (est.)

    Resident basis; registered basis ~12,235 · see page 3

    6,629

    Hypertension register

    +4.31% in 3 yrs · England +5.60%

    385

    SMI register

    10.2% of Cheshire West and Chester (LAD)'s

    1,165

    COPD register

    Reviews -2.26% in 3 yrs

    Forecast to 2030

    7,448

    Hypertension patients, 2030

    +819 on today

    78.3%

    QRISK ≥20% on statins, 2030

    +3.21pp over 3 yrs

    4.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    61.7%
    Asthma annual reviews trail England.

    Annual asthma reviews fell 4.5 pp over 2023 to 2025 to 61.7% (England 65.7%, +2.8 pp), leaving about 1,100 patients unreviewed.

    50.4%
    Diabetes control and SMI checks lag.

    Non-frail diabetes HbA1c control is 50.4% (England 57.4%), while SMI blood pressure checks fell 8.9 pp to 79.9% (England 83.4%, +4.4 pp).

    71.4%
    Current lipid and hypertension treatment above England.

    Lipid-lowering therapy in QRISK ≥ 20% reaches 71.4% (England 63.6%) and hypertension control is 72.2% (England 70.3%), despite hypertension control falling 4.9 pp.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger registered population of 38,799 patients with 96.2% White Census residents

    Winsford PCN serves 38,799 registered patients across five practices. The registered population is younger than benchmarks: 21.1% (8,207 patients) are aged 0-17, compared with 18.5% in Cheshire West and Chester (LAD), 19.2% in NHS Cheshire and Merseyside Integrated Care Board, and 19.6% in England. Patients aged 65+ comprise 17.6% (6,843 patients), below the LAD (20.3%), ICB (19.0%), and England (17.9%). Based on Census usual residents rather than registered patients, 96.2% are White (LAD 95.3%, ICB 93.0%, England 81.1%), leaving a 3.8% ethnic minority share. Projected list growth to 2030 is 2.2% under an unverified model.

    Age profile

    0–1721.1%
    18–6461.2%
    65+17.6%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.2%
    Asian1.6%
    Mixed1.2%
    Other0.5%
    Black0.4%

    Older people · falls rows are Cheshire West and Chester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire West and Chester LA)2,1092,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)50.4%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire West and Chester LA)8931,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire West and Chester LA)14.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 30.7% PCN-wide, ranging from 26.9% to 47.0% across practices

    Winsford PCN has 30.7% of registered patients in the Core20 most deprived quintile, exceeding Cheshire West and Chester (15.7%) and England (21.0%), and below the ICB (31.9%). Modelled practice shares average 31.5%, an unresolved 0.87 percentage point discrepancy. All five practices exceed England, ranging 20.1 pp: concentration peaks at Launceston Close Surgery (47.0%, 2,555 patients), while Swanlow Medical Centre carries the largest volume (3,286 patients, 31.3%). This split requires balancing intensive engagement at high-concentration practices with structured clinical recall across high-volume lists.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Launceston Close47.0% · 2,555 patients
    Swanlow31.3% · 3,286 patients
    High Street29.8% · 2,013 patients
    Willow Wood27.7% · 2,046 patients
    Weaver Vale26.9% · 2,335 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    385

    SMI register

    0.99% recorded prevalence

    314

    Learning disability register

    0.81% recorded prevalence

    8

    Care homes, 252 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Cheshire West and Chester (LAD), Census 2021

    The PCN records 314 patients on the learning disability register (0.8% prevalence vs 0.5% LAD, 0.6% ICB, and 0.6% England) and 385 on the severe mental illness register (1.0% vs 1.0% LAD, 1.1% ICB, and 1.0% England). Catchment facilities include 8 care homes with 252 beds.

    Severe mental illness: physical health checks

    SMI physical health checks fell over three years: BP checks fell 8.9 pp to 79.9% (England 83.4%, +4.4 pp), alcohol recording fell 7.3 pp to 80.5%, and BMI fell 7.0 pp to 82.0%. Coordinated recall could recover monitoring.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,629

    Hypertension register

    +4.31%

    Register growth, 3 yrs

    Cheshire West and Chester (LAD) +6.60% · England +5.60%

    −4.09pp

    BP control, under 80

    ≤140/90 · −2.15pp aged 80+

    +819

    More patients by 2030

    Forecast 7,448 (18.62%)

    Hypertension case-finding and control

    Hypertension prevalence is 17.1% (6,629 patients), above England (15.2%), Cheshire West and Chester (17.0%), and NHS Cheshire and Merseyside Integrated Care Board (16.8%). Current blood pressure control is 72.2% (England 70.3%) and blood pressure under 140/90 mmHg for under-80s is 71.3% (England 67.8%). However, three-year trajectories trail benchmarks: control in under-80s fell 4.1 pp over 2023 to 2025 (England +2.1 pp), and treatment to target fell 4.9 pp (England +2.5 pp). Denominators include personalised care adjustments. Declining blood pressure control against rising national benchmarks indicates a need to systematically recall hypertensive patients whose monitoring has lapsed.

    Lipids and statins

    Lipid-lowering therapy in high-risk patients reaches 71.4% for QRISK ≥ 20%, exceeding England (63.6%), Cheshire West and Chester (63.8%), and NHS Cheshire and Merseyside Integrated Care Board (63.2%). Therapy in chronic kidney disease reaches 75.4% (England 70.3%). Denominators include personalised care adjustments.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202692,244£1.80£1.71£1.86£166,039
    Cardiovascular (all), 2025114,077£3.69£4.37£3.33£420,944

    In 2026, 92,244 lipid-regulating drug items were prescribed at £1.80 per item (spend £166,039). The PCN spent £5,535 less than at England's unit cost (£1.86), but £8,302 more than at NHS Cheshire and Merseyside Integrated Care Board's unit cost (£1.71). Unit cost is not efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −6.75%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.62%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.9% (2,877 patients), above England (6.6%), and COPD prevalence is 3.0% (England 1.9%). Asthma management prescribing for ages 5-19 is 2,372 per 1,000 (England 1,488). Over 2023 to 2025, asthma reviews fell 4.5 pp to 61.7% (England 65.7%, +2.8 pp), leaving about 1,100 patients unreviewed. COPD reviews reach 75.5% (England 76.4%). Denominators include personalised care adjustments.

    Cancer register and children's immunisation

    Cancer prevalence is 3.7% (1,449 patients), below Cheshire West and Chester (4.8%) and England (3.8%). Age-5 MMR dose 2 reaches 96.1% (England 82.8%) and 4-in-1 booster coverage reaches 93.2% (England 80.9%), 1.8 pp below the 95.0% target. At High Street Practice Winsford, age-5 MMR second-dose coverage trails first-dose uptake by 8.7 pp (91.3% versus 100.0%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.6%

    England 91.0%

    6-in-1 complete primary course at 24 months96.1%

    England 92.2%

    MMR dose 1 at 24 months96.1%

    England 88.3%

    MMR dose 2 at age 596.1%

    England 82.8%

    4-in-1 pre-school booster at age 593.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, across NHS Cheshire and Merseyside ICB, 55.5% of cancers with a known stage (7,482 of 13,490) were diagnosed at stage 1 or 2, in line with England (55.3%) but 19.5 pp below the 75.0% national ambition. Known-stage completeness was 72.8% (13,490 of 18,522 registered cancers; England 67.0%). Reaching the 75.0% ambition would require about 2,640 additional early-stage diagnoses annually across the ICB. Early-stage shares varied from 87.1% in breast to 22.0% in oesophageal cancer, though some tumor types have small counts. These reflect ICB-level completeness rather than PCN performance. System-wide staging shortfalls mean primary care early detection and screening remain essential levers.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Mid Cheshire Hospitals NHS Foundation Trust met the 28-day faster diagnosis standard at 80.0% (standard 75.0%), against 87.4% at Countess of Chester Hospital NHS Foundation Trust, 80.2% at North Cheshire and Mersey NHS Foundation Trust, 77.2% across the ICB, and 79.3% in England. However, Mid Cheshire trailed the 85.0% 62-day standard at 71.1% (ICB 76.2%, England 71.2%) and the 96.0% 31-day standard at 86.2% (ICB 95.7%, England 92.5%). Diagnostic 6-week waits at Mid Cheshire were 5.2% for MRI and 1.1% for CT, below England (21.4% and 9.9%).

    Pathways within standard (%)Mid CheshireNorth Cheshire and MerseyCountess of ChesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)79.9580.2187.3777.2579.32
    31-day treatment (96%)86.2198.1793.4895.7192.50
    62-day referral to treatment (85%)71.1283.6783.2876.2371.16
    Diagnostic waits over 6 weeks (%)Mid CheshireNorth Cheshire and MerseyCountess of ChesterEngland
    MRI5.150.5311.2621.40
    CT1.092.324.189.92
    Echocardiography5.5128.0431.4428.48
    Colonoscopy30.3415.9826.4430.83
    Gastroscopy31.8920.2427.5229.02
    All 15 DM01 tests12.726.3420.1623.14
    Community services activityCheshire West and Chester residentsCheshire and Merseyside ICB
    Care contacts47,655541,280
    Referrals10,32597,150
    Patients with a contact18,585146,240

    Community services (residents of Cheshire West and Chester), Jun 2026 (provisional). In June 2026, community services recorded 47,655 contacts with Cheshire West and Chester residents. Adults aged 65 and over accounted for 25,095 of these contacts, representing 52.7% of all recorded activity. These figures capture borough-wide resident activity from the Community Services Dataset rather than PCN-specific contacts, illustrating the high share of community service resource dedicated to older residents across the wider local authority.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone contact varies by 37.8 pp across practices while overall satisfaction exceeds England

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Weaver Vale12926.988.4%79.6%89.4%
    Willow Wood14427.780.1%72.0%86.7%
    Launceston Close12847.085.7%80.7%85.3%
    High Street11129.876.6%83.3%84.9%
    Swanlow11831.350.6%71.5%81.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire West and Chester (LAD)AssetPCNCheshire West and Chester (LAD)
    Care homes (catchment)8 (252 beds)n/aSchools (catchment)30n/a
    Children's centres215Places of worship21231
    Libraries116Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)670
    Primary academies646Special schools15

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Standardised annual asthma review recall

    Asthma 12-month review (incl. PCAs) is 61.7% across 2,877 patients versus 65.7% in England (3.9 pp below) and 62.3% in the ICB, falling 4.5 pp over 2023 to 2025 (England +2.8 pp) and leaving 1,101 (about 1,100) unreviewed. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Coordinated SMI physical health checks

    On the 385-patient SMI register, 12-month BP checks fell 8.9 pp over 2023 to 2025 to 79.9% (England 83.4%, +4.4 pp; LAD 81.0%, +1.8 pp); alcohol recording fell 7.3 pp to 80.5% and BMI fell 7.0 pp to 82.0%. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Diabetes and hypertension control recall

    In 2024/25, non-frail diabetes HbA1c <= 58 mmol/mol is 50.4% (1,082/2,147; England 57.4%, ICB 56.2%) and frail <= 75 mmol/mol is 78.1% (563/721; England 81.9%); under-80 hypertension BP control (71.3%) fell 4.1 pp (England +2.1 pp). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and access workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Standardised annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Coordinated SMI physical health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Option 3 · Diabetes and hypertension control recall (p12)Diabetes without frailty: HbA1c at or below 58 mmol/mol · Diabetes with frailty: HbA1c at or below 75 mmol/mol · IFCC-HbA1c <= 58 mmol/mol in patients with diabetes without frailty (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15